Centene (CNC) Is Back In The Spotlight, What Is Driving Attention?

Centene (CNC) is back in focus after outlining a National Performance-Based Gold Card Program and extending its CHOICE Arrangements benefits footprint, two moves that reshape how providers and members interact with the insurer.

These product and benefit updates land after a strong share price run. Centene’s stock has a year to date share price return of 65.53% and a 1 year total shareholder return of 96.09%. Over the past 3 and 5 years, total shareholder returns have been slightly negative, which points to strong recent momentum following a tougher longer stretch.

Capitalize on Centene’s momentum and focus on healthcare efficiency by scanning a curated set of 33 healthcare AI stocks that could be tapping similar themes in cost control and care delivery.

Centene now trades near its average analyst target while a large intrinsic value discount flag still sits on the screen. Is the recent rerating already enough, or is the gap mispriced?

Most Popular Narrative: 3.6% Undervalued

On the most followed view, Centene’s fair value sits at $71.78, a touch above the last close at $69.16. This puts the spotlight on whether its margin rebuild can close that gap over time.

Centene's effort to restore Medicaid margins, supported by a 2026 composite rate yield outlook of roughly 5% and a targeted full year Medicaid HBR of about 93.5%, continues to point to earnings power that some investors may not yet fully reflect in valuation, with potential impact on segment net margins.

See why 57 investors see Centene as 4% undervalued.

Result: Fair Value of $71.78 (UNDERVALUED)

Still, the Centene narrative leans heavily on Medicaid and Marketplace execution, so slower margin recovery or less supportive policy decisions could quickly challenge this view that the stock is 3.6% undervalued.

Find out about the key risks to this Centene narrative.

Next Steps

Mixed signals on Centene so far and wondering how to weigh them. To act quickly, review the full picture of both risk and reward in the 3 key rewards and 1 important warning sign.

Looking for more Centene-sized opportunities?

Do not stop with Centene. Use the Simply Wall Street Screener to quickly surface fresh ideas that match your risk, income, and quality preferences so you are not reacting late.

• Target potential upside by scanning a hand picked pool of companies that combine quality and attractive pricing through the 33 high quality undervalued stocks.
• Strengthen income potential by focusing on businesses in the 8 dividend fortresses that offer higher yields with an emphasis on durability.
• Cut concentration risk by spreading capital across companies in the 32 resilient stocks with low risk scores that aim for steadier performance and fewer surprises.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com